PYPD (PolyPid) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PolyPid FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PolyPid's Free Cash Flow for the three months ended in Dec. 2024 was $0.00 Mil. PolyPid's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, PolyPid's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, PolyPid's current FCF Yield % is -86.16%.

The historical rank and industry rank for PolyPid's FCF Margin % or its related term are showing as below:

PYPD's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -129.705
* Ranked among companies with meaningful FCF Margin % only.

PolyPid FCF Margin % Historical Data

The historical data trend for PolyPid's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPid FCF Margin % Chart

PolyPid Annual Data

Trend

Dec13

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

PolyPid Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PolyPid's FCF Margin %

For the Biotechnology subindustry, PolyPid's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPid's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PolyPid's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PolyPid's FCF Margin % falls into.

Save Embed

;

Save Embed

;

PolyPid FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PolyPid's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-22.039	/	0
	=	%

PolyPid's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

PolyPid FCF Margin % Related Terms

Thank you for viewing the detailed overview of PolyPid's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPid Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PolyPid Ltd (NAS:PYPD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Hasivim Street, P.O Box 7126, Petach Tikva, ISR, 495376

Website

https://www.polypid.com

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.